Preclinical evaluation of gold-DTDTPA nanoparticles as theranostic agents in prostate cancer radiotherapy.
Butterworth KT, Nicol JR, Ghita M, Rosa S, Chaudhary P, McGarry CK, McCarthy HO, Jimenez-Sanchez G, Bazzi R, Roux S, Tillement O, Coulter JA, Prise KM.
Butterworth KT, et al. Among authors: ghita m.
Nanomedicine (Lond). 2016 Aug;11(16):2035-47. doi: 10.2217/nnm-2016-0062. Epub 2016 Jul 27.
Nanomedicine (Lond). 2016.
PMID: 27463088
Free article.